Differentially expressed miRNAs in retinoblastoma

Gene

Volumn 512, Issue 2, 2013, Pages 294-299

  Martin, Joshua ^a   Bryar, Paul ^b   Mets, Marilyn ^a,b   Weinstein, Joanna ^a,b   Jones, Aunica ^a   Martin, Alissa ^a   Vanin, Elio F ^a   Scholtens, Denise ^b   Costa, Fabricio F ^a   Soares, Marcelo B ^a,b   Laurie, Nikia A ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

MicroRNA; Retina; Taqman low density array

Indexed keywords

MICRORNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINOBLASTOMA; RNA ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICRORNAS; RETINAL NEOPLASMS; RETINOBLASTOMA; RNA, NEOPLASM;

EID: 84870360348     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.129     Document Type: Article

References (44)

1. Bandres E., et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 2009, 125:2737-2743.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995, 57:289-300.
3. Caporali A., Emanueli C. MicroRNA regulation in angiogenesis. Vascul. Pharmacol. 2011, 55:79-86.
4. Chen X., et al. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int. J. Cancer 2011, 130:1607-1613.
5. Cogswell J.P., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
6. Conkrite K., et al. miR-17 92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev. 2011, 25:1734-1745.
7. Corson T.W., Gallie B.L. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 2007, 46:617-634.
8. Dalgard C.L., Gonzalez M., deNiro J.E., O'Brien J.M. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 2009, 50:4542-4551.
9. Decembrini S., et al. MicroRNAs couple cell fate and developmental timing in retina. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21179-21184.
10. Eckstein F. The versatility of oligonucleotides as potential therapeutics. Expert. Opin. Biol. Ther. 2007, 7:1021-1034.
11. Ferretti E., et al. MicroRNA profiling in human medulloblastoma. Int. J. Cancer 2009, 124:568-577.
12. Gao W., Shen H., Liu L., Xu J., Xu J., Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J. Cancer Res. Clin. Oncol. 2011, 137:557-566.
13. Henson B.J., Bhattacharjee S., O'Dee D.M., Feingold E., Gollin S.M. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 2009, 48:569-582.
14. Hu W., et al. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol. Cell 2010, 38:689-699.
15. Huang J.C., et al. Using expression profiling data to identify human microRNA targets. Nat. Methods 2007, 4:1045-1049.
16. Huang Y.W., et al. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 2009, 69:9038-9046.
17. Karolina D.S., et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 2011, 6:e22839.
18. Katada T., et al. microRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol. 2009, 34:537-542.
19. Kota S.K., Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discov. Today 2010, 15:733-740.
20. Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., Tuschl T. New microRNAs from mouse and human. RNA 2003, 9:175-179.
21. Lambertz I., et al. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ. 2010, 17:633-641.
22. Laurie N., et al. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol. Cell. Biol. 2009, 29:6268-6282.
23. Ling B., Wang G.X., Long G., Qiu J.H., Hu Z.L. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. J. Cancer Res. Clin. Oncol. 2012, 138:1355-1361.
24. Loscher C.J., et al. Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol. 2007, 8:R248.
25. Macpherson D. Insights from mouse models into human retinoblastoma. Cell Div. 2008, 3:9.
26. Mu G., et al. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas. Hum. Pathol. 2010, 41:493-502.
27. Sen C.K., Gordillo G.M., Khanna S., Roy S. Micromanaging vascular biology: tiny microRNAs play big band. J. Vasc. Res. 2009, 46:527-540.
28. Shen J., et al. MicroRNAs regulate ocular neovascularization. Mol. Ther. 2008, 16:1208-1216.
29. Shen R., Pan S., Qi S., Lin X., Cheng S. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem. Biophys. Res. Commun. 2010, 394:1047-1052.
30. Shi W., et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int. J. Cancer 2010, 126:2036-2048.
31. Shields C.L., Shields J.A. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr. Opin. Ophthalmol. 2010, 21:203-212.
32. Shields C.L., Shields J.A., Baez K., Cater J.R., De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994, 73:692-698.
33. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. (Article3).
34. Sreenivasan S., Thirumalai K., Danda R., Krishnakumar S. Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. Curr. Eye Res. 2012, 37:421-428.
35. Thayanithy V., et al. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 2012, 50:171-181.
36. Thum T., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
37. Tsai K.W., et al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int. J. Cancer 2011, 129:2600-2610.
38. Valastyan S., et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
39. Wang S., Olson E.N. AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev. 2009, 19:205-211.
40. Wang V., Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009, 23:15-23.
41. Williams A.H., Liu N., van Rooij E., Olson E.N. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009, 21:461-469.
42. Wu J., et al. miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 2010, 9:1809-1818.
43. Xu X., et al. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells. Int. J. Oncol. 2011, 38:1385-1393.
44. Zhao J.J., et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv. Syst. 2009, 25:13-20.